640
Participants
Start Date
October 19, 2020
Primary Completion Date
June 2, 2026
Study Completion Date
June 2, 2026
Durvalumab
Durvalumab intravenous infusion
Placebo
Durvalumab matching placebo for intravenous infusion
cisplatin + fluorouracil
cisplatin + fluorouracil, as per Standard of Care
cisplatin + capecitabine
cisplatin + capecitabine, as per Standard of Care
Radiation
50-64Gy in total
Research Site, Taoyuan District
Research Site, Taichung
Research Site, Tainan City
Research Site, Brussels
Research Site, Liège
Research Site, Namur
Research Site, Charleroi
Research Site, Barcelona
Research Site, Taipei
Research Site, Bangkok
Research Site, Bangkok
Research Site, Bangkok
Research Site, Bangkok
Research Site, Taipei
Research Site, Córdoba
Research Site, Suwon
Research Site, Diyarbakır
Research Site, Chanthaburi
Research Site, Fairfax
Research Site, Besançon
Research Site, Erzurum
Research Site, Morgantown
Research Site, Madrid
Research Site, Madrid
Research Site, Madrid
Research Site, Atlanta
Research Site, Pamplona
Research Site, Chihuahua City
Research Site, Montpellier
Research Site, Izmir
Research Site, Santander
Research Site, Khon Kaen
Research Site, Louisville
Research Site, Taichung
Research Site, Daegu
Research Site, Changzhi
Research Site, Changhua
Research Site, Zaragoza
Research Site, Chiang Mai
Research Site, Reims
Research Site, Lille
Research Site, Cuernavaca
Research Site, Van
Research Site, Monterrey
Research Site, Strasbourg
Research Site, Lyon
Research Site, Dallas
Research Site, Rouen
Research Site, Kaohsiung City
Research Site, Kaohsiung City
Research Site, Kaohsiung City
Research Site, Hat Yai
Research Site, Veracruz
Research Site, Villejuif
Research Site, Mérida
Research Site, Hanoi
Research Site, Beijing
Research Site, Beijing
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Zhenjiang
Research Site, Xuzhou
Research Site, Liangyugang
Research Site, Huai'an
Research Site, Yangzhou
Research Site, Nantong
Research Site, Hefei
Research Site, Bengbu
Research Site, Obninsk
Research Site, Jinan
Research Site, Qingdao
Research Site, Tianjin
Research Site, Fuzhou
Research Site, Fuzhou
Research Site, Krasnodar
Research Site, Quanzhou
Research Site, Chongqing
Research Site, Changsha
Research Site, Zhengzhou
Research Site, Ufa
Research Site, Chelyabinsk
Research Site, Anyang
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Shenzhen
Research Site, Jieyang
Research Site, Chengdu
Research Site, Yekaterinburg
Research Site, Kunming
Research Site, Ho Chi Minh City
Research Site, Xi'an
Research Site, Tyumen
Research Site, Barretos
Research Site, Fortaleza
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São José do Rio Preto
Research Site, Vitória
Research Site, Barrie
Research Site, Greater Sudbury
Research Site, Hangzhou
Research Site, Goztepe Istanbul
Research Site, Ho Chi Minh City
Research Site, Bunkyō City
Research Site, Chūōku
Research Site, Hidaka-shi
Research Site, Hirakata-shi
Research Site, Hiroshima
Research Site, Kashiwa
Research Site, Kitaadachi-gun
Research Site, Kōtoku
Research Site, Kumamoto
Research Site, Maebashi
Research Site, Matsuyama
Research Site, Niigata
Research Site, Okayama
Research Site, Osaka
Research Site, Osaka
Research Site, Ota-shi
Research Site, Sendai
Research Site, Shinagawa-ku
Research Site, Yokohama
Research Site, Yokohama
Research Site, Katowice
Research Site, Krakow
Research Site, Lodz
Research Site, Siedlce
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Ankara
Lead Sponsor
AstraZeneca
INDUSTRY